Asia Business News | Tuesday, October 07, 2008
RSS 2.0  
ADIPEC 2008 - Powering the World - Fuelling the Future
LIVING CELL TECHNOLOGIES LIMITED ASX: LCT - Living Cell Technologies Granted Diabetes Patent in the US - Mr David Collinson, CEO & Executive Director



About LIVING CELL TECHNOLOGIES LIMITED

Living Cell Technologies Ltd (LCT) is an advanced biotechnology company currently listed on the Australian Stock Exchange. LCT’s focus is on market-driven encapsulated living cell products, for the treatment of Huntington's disease, haemophilia and insulin-dependent diabetes. LCT’s business was formed in 1987 to research cell extraction and to develop procedures for advanced living-cell replacement therapies.

About Boardroomradio

Sydney-based Boardroomradio (BRR) is an Investor Relations multi-media portal delivering audio webcasts to the investment community, including brokers, fund managers, analysts, and private investors.



 
   LIVING CELL TECHNOLOGIES LIMITED  
   BOARDROOMRADIO  
   ABN NEWSWIRE